Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$191.51 - $216.16 $9.92 Million - $11.2 Million
51,806 Added 10.11%
564,465 $120 Million
Q2 2023

Aug 11, 2023

SELL
$187.64 - $206.25 $131 Million - $144 Million
-698,912 Reduced 57.69%
512,659 $98.7 Million
Q1 2023

May 12, 2023

SELL
$127.59 - $203.08 $66.9 Million - $107 Million
-524,563 Reduced 30.21%
1,211,571 $245 Million
Q4 2022

Feb 10, 2023

BUY
$117.37 - $139.17 $8.41 Million - $9.97 Million
71,633 Added 4.3%
1,736,134 $223 Million
Q3 2022

Nov 14, 2022

BUY
$135.27 - $180.11 $27.8 Million - $37 Million
205,549 Added 14.09%
1,664,501 $228 Million
Q2 2022

Aug 11, 2022

SELL
$108.81 - $179.33 $14.4 Million - $23.7 Million
-132,405 Reduced 8.32%
1,458,952 $258 Million
Q1 2022

May 13, 2022

BUY
$119.61 - $157.85 $12.3 Million - $16.2 Million
102,662 Added 6.9%
1,591,357 $229 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $7.26 Million - $9.72 Million
50,922 Added 3.54%
1,488,695 $230 Million
Q3 2021

Nov 12, 2021

BUY
$142.45 - $169.82 $14.4 Million - $17.2 Million
101,325 Added 7.58%
1,437,773 $244 Million
Q2 2021

Aug 13, 2021

SELL
$135.08 - $161.1 $25.9 Million - $30.9 Million
-191,617 Reduced 12.54%
1,336,448 $211 Million
Q1 2021

May 13, 2021

BUY
$137.51 - $190.8 $30.2 Million - $41.8 Million
219,334 Added 16.76%
1,528,065 $212 Million
Q4 2020

Feb 10, 2021

BUY
$164.63 - $211.93 $215 Million - $277 Million
1,308,731 New
1,308,731 $229 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.